Skip to main content
logo
Indogulf Cropsciences Limited (NSE:IGCL)
India flag India · Delayed Price · Currency is INR
109.40
-2.50 (-2.23%)
At close: Jul 31, 2025, 3:30 PM IST

CTI BioPharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22
Net Income
314.72282.33224.23263.63
Depreciation & Amortization
105.9699.2890.7478.31
Other Amortization
-3.795.47.7
Loss (Gain) From Sale of Assets
-13.4936.65-1.63-0.78
Loss (Gain) From Sale of Investments
----0.97
Other Operating Activities
156.21136.4689.4453.14
Change in Accounts Receivable
-16.03-449.04-348.67-350.86
Change in Inventory
-747.68138.72-572.84163.12
Change in Accounts Payable
245.6279.01-192.71-130.68
Change in Other Net Operating Assets
-192.866.2135.94-152.66
Operating Cash Flow
-147.57533.4-570.1-70.05
Capital Expenditures
-421.79-248.48-201.61-132.06
Sale of Property, Plant & Equipment
18.3186.316.499.64
Investment in Securities
---20
Other Investing Activities
4.899.922.182.27
Investing Cash Flow
-398.6-52.25-192.94-100.15
Short-Term Debt Issued
369.48-797.08530.26
Long-Term Debt Issued
289.21-81.31-
Total Debt Issued
658.69-878.39530.26
Short-Term Debt Repaid
--312.9--
Long-Term Debt Repaid
-25.15-51.02-15.33-314
Total Debt Repaid
-25.15-363.92-15.33-314
Net Debt Issued (Repaid)
633.54-363.92863.06216.26
Issuance of Common Stock
120---
Other Financing Activities
-139.68-124.93-111.08-55.32
Financing Cash Flow
613.86-488.85751.98160.94
Miscellaneous Cash Flow Adjustments
--0.01--
Net Cash Flow
67.69-7.71-11.06-9.26
Free Cash Flow
-569.36284.92-771.71-202.11
Free Cash Flow Margin
-9.58%5.14%-13.99%-4.13%
Free Cash Flow Per Share
-12.7012.12-32.81-8.59
Cash Interest Paid
139.68124.93111.0955.32
Cash Income Tax Paid
117.1663.8107.996.3
Levered Free Cash Flow
-732.84161.98-965.22-
Unlevered Free Cash Flow
-642.09239.19-896.83-
Change in Net Working Capital
687.14-68.161,069-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.